In The Global IP Matrix Issue 23, Evgeny Alexandrov of Gorodissky & Partners examines how Russia’s legal framework addresses compulsory licensing of pharmaceutical patents during crises and beyond.

Discover how the USPTO’s termination of 3,100 patent applications due to signature fraud is reshaping the conversation around practitioner ethics and IP system integrity, in this article by Michele S. Katz of Advitam IP.